Page last updated: 2024-10-22

alosetron and Carcinoid Tumor

alosetron has been researched along with Carcinoid Tumor in 1 studies

alosetron : A pyrido[4,3-b]indole compound having a 5-methyl-1H-imidazol-4-ylmethyl group at the 2-position.

Carcinoid Tumor: A usually small, slow-growing neoplasm composed of islands of rounded, oxyphilic, or spindle-shaped cells of medium size, with moderately small vesicular nuclei, and covered by intact mucosa with a yellow cut surface. The tumor can occur anywhere in the gastrointestinal tract (and in the lungs and other sites); approximately 90% arise in the appendix. It is now established that these tumors are of neuroendocrine origin and derive from a primitive stem cell. (From Stedman, 25th ed & Holland et al., Cancer Medicine, 3d ed, p1182)

Research Excerpts

ExcerptRelevanceReference
"In 27 patients with carcinoid diarrhoea, symptoms were recorded daily and gastrointestinal transit was measured by scintigraphy in a three dose (0."2.69Medium-term effects of a new 5HT3 antagonist, alosetron, in patients with carcinoid diarrhoea. ( Burton, DD; Camilleri, M; Forstrom, LA; Pitot, HC; Rubin, J; Saslow, SB; Scolapio, JS; Thomforde, GM; Zinsmeister, AR, 1998)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Saslow, SB1
Scolapio, JS1
Camilleri, M1
Forstrom, LA1
Thomforde, GM1
Burton, DD1
Rubin, J1
Pitot, HC1
Zinsmeister, AR1

Trials

1 trial available for alosetron and Carcinoid Tumor

ArticleYear
Medium-term effects of a new 5HT3 antagonist, alosetron, in patients with carcinoid diarrhoea.
    Gut, 1998, Volume: 42, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Carbolines; Carcinoid Tumor; Colon; Diarrhea; Double-Blind Method; D

1998